Related Experiment Video
Updated: Jun 8, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Regulatory T cells as a potent target for controlling bone loss
Feng-Lai Yuan1, Xia Li, Wei-Guo Lu
1The Third Hospital Affiliated to Nantong University, Wuxi, Jiangsu 214041, China. bjjq88@163.com
Biochemical and Biophysical Research Communications
|October 6, 2010
Summary
Regulatory T cells (Tregs) show promise in treating metabolic bone diseases like osteoporosis and rheumatoid arthritis by inhibiting bone-resorbing cells. Increasing Treg numbers effectively prevents and treats bone loss in preclinical models.
Area of Science:
- Immunology
- Endocrinology
- Rheumatology
Background:
- Metabolic bone diseases, including rheumatoid arthritis (RA) and osteoporosis, cause significant global pain and disability.
- Current treatments for bone destruction are limited due to incomplete understanding of underlying molecular mechanisms.
- Regulatory T cells (Tregs) are increasingly recognized for their role in immune suppression and autoimmune disease pathogenesis.
Purpose of the Study:
- To discuss the biological characteristics of Tregs.
- To summarize recent findings on the role of Tregs in the pathogenesis of bone loss.
- To explore the therapeutic potential of Tregs in metabolic bone diseases.
Main Methods:
- In vitro studies demonstrating Treg inhibition of osteoclast differentiation and function.
- In vivo studies using mouse models (TNF transgenic, ovariectomy-induced bone loss) to assess Treg efficacy.
- Methods to increase Treg numbers, including FoxP3 overexpression and anti-CD28 superagonist antibody treatment.
Main Results:
- Tregs directly inhibit osteoclast activity in vitro.
- Treg administration or augmentation prevented and reversed bone loss in multiple mouse models.
- Increased Treg numbers via FoxP3 overexpression or specific antibody treatments protected against bone destruction.
Conclusions:
- Tregs play a critical role in regulating bone metabolism and preventing bone loss.
- Modulating Treg populations presents a promising therapeutic strategy for metabolic bone diseases.
- Further research into Treg-based therapies could lead to improved treatments for conditions like RA and osteoporosis.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...